Filtros de búsqueda

Lista de obras de Matteo Lambertini

Adjuvant chemotherapy in biliary tract cancer patients: A systematic review and meta-analysis of randomized controlled trials

scientific article published on 19 March 2020

Adjuvant trastuzumab: a 10-year overview of its benefit.

artículo científico publicado en 2016

Anthracycline and taxane-based chemotherapy versus docetaxel and cyclophosphamide in the adjuvant treatment of HER2-negative breast cancer patients: a systematic review and meta-analysis of randomized controlled trials

scientific article published on 21 November 2018

Anti-Mullerian hormone: determination of ovarian reserve in early breast cancer patients

artículo científico

BREAST CANCER SCREENING OF MUTATION CARRIERS IN THE ERA OF COVID-19 PANDEMIC

scientific article published on 17 June 2020

Breast cancer diagnosed during pregnancy is associated with enrichment of non-silent mutations, mismatch repair deficiency signature and mucin mutations

artículo científico publicado en 2018

Breast cancer treatment-induced cardiotoxicity

artículo científico publicado en 2017

Burning Questions in the Oncofertility Counseling of Young Breast Cancer Patients

scientific article published on 04 September 2020

Call for assessing treatment-induced gonadotoxicity of platinum-based chemotherapy in early breast cancer

artículo científico publicado en 2020

Call for ensuring cancer care continuity during COVID-19 pandemic

scientific article published on 01 May 2020

Cancer Surveillance in Healthy Carriers of Germline Pathogenic Variants in BRCA1/2: A Review of Secondary Prevention Guidelines

artículo científico publicado en 2020

Cancer and fertility preservation: international recommendations from an expert meeting

artículo científico publicado en 2016

Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists' perspective

artículo científico publicado en 2020

Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO).

artículo científico publicado en 2016

Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study

artículo científico publicado en 2020

Clinical utility of genomic signatures in young breast cancer patients: a systematic review

scientific article published on 25 September 2020

Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis

artículo científico publicado en 2017

Controversies about fertility and pregnancy issues in young breast cancer patients: current state of the art.

artículo científico publicado en 2017

Controversies in oncology: which adjuvant endocrine therapy is to be given to premenopausal patients with hormone receptor-positive breast cancer?

artículo científico publicado en 2018

Current State of the Art in the Adjuvant Systemic Treatment of Premenopausal Patients With Early Breast Cancer

scientific article published on 29 June 2020

Debated Role of Ovarian Protection With Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Women With Cancer

artículo científico publicado en 2016

Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis

scientific article published on 01 November 2019

Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial

artículo científico publicado en 2019

Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial

artículo científico publicado en 2019

Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies.

artículo científico publicado en 2016

ESHRE guideline: female fertility preservation

scientific article published on 14 November 2020

ESMO Open special series on new emerging targets in cancer immunotherapy

artículo científico publicado en 2020

ESMO Open: news in breast cancer 2019

artículo científico publicado en 2020

Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib.

artículo científico publicado en 2017

Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysis

artículo científico publicado en 2020

European Society for Medical Oncology (ESMO) 2018 Congress Twitter analysis: from ethics to results through the understanding of communication and interaction flows

artículo científico publicado en 2020

Exploring the safety of chemotherapy for treating breast cancer during pregnancy

artículo científico

Fertility and pregnancy issues in BRCA-mutated breast cancer patients.

artículo científico publicado en 2017

Fertility counseling of young breast cancer patients

artículo científico publicado en 2013

Fertility issues in young breast cancer patients: what women want

artículo científico publicado en 2014

Follow-up strategies for women treated for early breast cancer

artículo científico publicado en 2016

Gender-specific aspects related to type of fertility preservation strategies and access to fertility care

scientific article published on 01 October 2020

Gonadotropin Releasing Hormone Agonists Have an Anti-apoptotic Effect on Cumulus Cells

scientific article published on 30 November 2019

Gonadotropin-releasing hormone analogs for ovarian function protection during chemotherapy in young early breast cancer patients: the last piece of the puzzle?

artículo científico publicado en 2017

Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials

artículo científico publicado en 2013

Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting

scientific article published on 01 October 2019

Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: results of an observational study.

artículo científico publicado en 2017

How I treat metastatic triple-negative breast cancer

scientific article published on 13 May 2019

How reliable are the available safety data on hormonal stimulation for fertility preservation in young women with newly diagnosed early breast cancer?

artículo científico publicado en 2018

Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis

publication published on 26 October 2021

Is it safe to perform a controlled ovarian stimulation for assisted reproduction in young breast cancer survivors?

scientific article published on 17 December 2015

Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak

artículo científico publicado en 2020

Knowledge, attitudes and practice of physicians towards fertility and pregnancy-related issues in youngBRCA-mutated breast cancer patients

scientific article published on 10 January 2019

Letrozole withdrawal response in locally advanced breast cancer

artículo científico publicado en 2011

Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status.

artículo científico publicado en 2017

Lucitanib for the Treatment of HR+/HER2- Metastatic Breast Cancer: Results from the Multicohort Phase II FINESSE Study

scientific article published on 16 October 2019

Management of young women with early breast cancer

artículo científico publicado en 2018

Multicenter evaluation of breast cancer patients' satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemic

artículo científico publicado en 2021

New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an "ESMO Open - Cancer Horizons" Series

scientific article published on 12 June 2019

New insights on the role of luteinizing hormone releasing hormone agonists in premenopausal early breast cancer patients.

artículo científico publicado en 2015

News on the medical treatment of young women with early-stage HER2-negative breast cancer

artículo científico publicado en 2016

Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer.

artículo científico publicado en 2017

Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?

scientific article published on 09 March 2019

Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial

artículo científico publicado en 2015

Ovarian protection with gonadotropin-releasing hormone agonists during chemotherapy in cancer patients: From biological evidence to clinical application

artículo científico publicado en 2018

Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.

artículo científico publicado en 2015

Patterns of Care and Clinical Outcomes of First-Line Trastuzumab-Based Therapy in HER2-Positive Metastatic Breast Cancer Patients Relapsing After (Neo)Adjuvant Trastuzumab: An Italian Multicenter Retrospective Cohort Study.

artículo científico publicado en 2015

Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study

artículo científico publicado en 2017

Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial

artículo científico publicado en 2015

Pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors.

artículo científico publicado en 2015

Pharmacotherapy to protect ovarian function and fertility during cancer treatment

artículo científico publicado en 2017

Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis

artículo científico publicado en 2018

Post-neoadjuvant treatment and the management of residual disease in breast cancer: state of the art and perspectives

scientific article published on 25 February 2019

Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials

scientific article published on 18 October 2018

Pregnancy after breast cancer: Results from a prospective cohort of young women with breast cancer

artículo científico publicado en 2020

Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrence

artículo científico publicado en 2015

Prognostic role of distant disease-free interval from completion of adjuvant trastuzumab in HER2-positive early breast cancer: analysis from the ALTTO (BIG 2-06) trial

artículo científico publicado en 2020

Programmed Cell Death-Ligand 2: A Neglected But Important Target in the Immune Response to Cancer?

artículo científico publicado en 2020

Radiation therapy during the coronavirus disease 2019 (covid-19) pandemic in Italy: a view of the nation's young oncologists

scientific article published on 01 April 2020

Radiation therapy for young women with early breast cancer: Current state of the art

artículo científico publicado en 2019

Reply to S. A. Narod et al

artículo científico publicado en 2020

Reply to the letter to the editor ‘Can ovarian suppression with gonadotropin releasing hormone analogs (GnRHa) preserve fertility in cancer patients?’ by Rodriguez-Wallberg et al

artículo científico publicado en 2015

Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies

artículo científico publicado en 2016

Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients

artículo científico publicado en 2017

Risk of adverse events with the addition of targeted agents to endocrine therapy in patients with hormone receptor-positive metastatic breast cancer: A systematic review and meta-analysis.

artículo científico publicado en 2017

Role of fulvestrant in the treatment of postmenopausal metastatic breast cancer patients

artículo científico publicado en 2016

Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis.

artículo científico publicado en 2018

State of the art on oocyte cryopreservation in female cancer patients: A critical review of the literature

artículo científico publicado en 2017

Stevens-Johnson syndrome after treatment with bendamustine

artículo científico publicado en 2012

Strategies for fertility preservation in young early breast cancer patients

artículo científico publicado en 2014

Survival of patients with metastatic melanoma and brain metastases in the era of MAP-kinase inhibitors and immunologic checkpoint blockade antibodies: A systematic review.

artículo científico publicado en 2016

Targeted agents for cancer treatment during pregnancy.

artículo científico

Temporary Ovarian Suppression With Gonadotropin-Releasing Hormone Agonist During Chemotherapy for Fertility Preservation: Toward the End of the Debate?

artículo científico publicado en 2015

Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: A GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology

artículo científico publicado en 2016

The PREgnancy and FERtility (PREFER) study: an Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patients.

artículo científico publicado en 2017

The burden of breast cancer from China to Italy

artículo científico publicado en 2014

The five "Ws" for bone pain due to the administration of granulocyte-colony stimulating factors (G-CSFs).

artículo científico publicado en 2013

The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients.

artículo científico publicado en 2016

Trastuzumab as first-line therapy in HER2-positive metastatic breast cancer patients

artículo científico

Trastuzumab emtansine (T-DM1) as adjuvant treatment of HER2-positive early breast cancer: safety and efficacy

artículo científico publicado en 2020

Treatment with aromatase inhibitors and markers of cardiovascular disease.

artículo científico publicado en 2016

Treatment-induced early menopause and the protective role of gonadotropin-releasing hormone agonists during chemotherapy

scientific article published on 09 May 2018

Tumor-infiltrating lymphocytes in breast cancer according to tumor subtype: Current state of the art.

artículo científico publicado en 2017

Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: A meta-analysis of randomized controlled trials

artículo científico publicado en 2017

Twenty years of anti-HER2 therapy-associated cardiotoxicity

artículo científico publicado en 2016

Update on fertility preservation in young women undergoing breast cancer and ovarian cancer therapy.

artículo científico

Update on the Management of Breast Cancer during Pregnancy

artículo científico publicado en 2020

Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer

What Medical Oncologist Residents Think about the Italian Speciality Schools: A Survey of the Italian Association of Medical Oncology (AIOM) on Educational, Clinical and Research Activities

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda